NPO Petrovax Pharm has reported on the start of its medicinal products’ supply to Armenia. The export to Armenia is a significant event towards broadening the company’s geographical expansion.
Polyoxidonium, an effective and safe product with a comprehensive therapeutic effect and which has been successfully used in Russian healthcare for about 20 years, became the first medicinal product in the export portfolio.
Petrovax Pharm markets its products in Armenia in the frameworks of its partnership with OOO VagaPharm, a leading drug vendor in Armenian market.
The Company’s entry to international markets is one of the NPO Petrovax Pharm’s strategic goals. The original portfolio of innovative products and high operating standards compliant with international GMP standards enable Petrovax to successfully complete internationally and make a good potential for company’s export capabilities. Since 2005 Petrovax has been working towards export and today it supplies its products to the Ukraine, Belarus, Kazakhstan, Kyrgyz Republic, Armenia, Azerbaijan, Uzbekistan, Georgia, Moldova and Slovakia. The Company’s plans include new markets and export of its products to Czech Republic, Poland, Hungary, Venezuela, Mongolia, Vietnam and Iran.